Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
Patent
1995-05-01
1997-09-16
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
A61K 3165
Patent
active
056681224
ABSTRACT:
The present invention provides a method to treat susceptible cancers in humans comprising administering a cancer-treating amount of a member of the tetracycline family or a pharmaceutically acceptable salt thereof. Doxycycline, minocycline and tetracycline are utilized in the preferred method. Preferred methods of the present invention treat osteo-, breast, lung, prostate or Kaposi's cancers. Other aspects of the invention are described in the full application.
REFERENCES:
patent: 4791991 (1988-12-01), Umemura et al.
patent: 5045538 (1991-09-01), Schneider et al.
patent: 5321017 (1994-06-01), Golub et al.
Tamargo, R.J., Bok, R.A. and Brem, H., "Angiogenesis Inhibition by Minocycline," 51 Cancer Research 672 (Jan. 15, 1991).
Golub, L.M., Ciancio, S., Ramamurthy, N.S., Leung, M., McNamara, T.F., "Low-dose doxycycline therapy: Effect on gingival and crevicular fluid collagenase activity in humans," 25 J. Periodont. Res. 321 (1990).
Ramamurthy, N.S., Vernillo, A.T., Lee, H.-M., Golub, L.M., Rifkin, B.R., "The Effect of Tetracyclines on Collagenase Activity in UMR 106-01 RAT Osteoblastic Osteosarcoma Cells," Res. Comm. in Chem. Pathol. and Pharmac., vol. 70, No. 3, pp. 323-335 (Dec. 1990).
van der Bogert, C., Dontje, B.H.J., Holtrop, M., Melis, T.E., Romijn, C., van Dongen, J.W., Kroon, A.M., "Arrest of the Proliferation of Renal and Prostate Carcinomas of Human Origin by Inhibition of Mitochondrial Protein Synthesis," 46 Cancer Research 3283 (Jul. 1986).
Zucker, S., Lysik, R.M., Ramamurthy, N.S., Golub, L.M., Wieman, J.M., Wilkie, D.P., "Diversity of Melanoma Plasma Membrane Proteinases: Inhibition of Collagenolytic and Cytolytic Activities by Minocycline," JNCI, vol. 75, No. 3, pp. 517-525 (Sep. 1985).
Golub, L.M., Lee, H.M., Lehrer, G., Nemiroff, A., McNamara, T.F., Kaplan, R., and Ramamurthy, N.S., "Minocycline reduces gingival collagenolytic activity during diabetes," 18 J. of Periodont. Research 516 (1983).
Fife Rose S.
Sledge George W.
LandOfFree
Method to treat cancer with tetracyclines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method to treat cancer with tetracyclines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method to treat cancer with tetracyclines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-218320